Serum levels of activin A and inhibin A are not related to the increased susceptibility to pre-eclampsia in type I diabetic pregnancies

Acta Obstetricia et Gynecologica Scandinavica

Volumn 85, Issue 2, 2006, Pages 143-147

  Ekbom, Pia ^a   Damm, Peter ^a   Andersson, Anna Maria ^a   Erik Skakkebæk, Niels ^a   Feldt Rasmussen, Ulla ^a   Mathiesen, Elisabeth ^a  

^a Rigshospitalet   (Denmark)

Author keywords

Activin A; Diabetes mellitus; Inhibin A; Pre eclampsia; Pregnancy; Type I

Indexed keywords

ACTIVIN A; INHIBIN A; ACTIVIN; INHIBIN;

ADULT; AGE DISTRIBUTION; ARTICLE; BODY MASS; CONTROLLED STUDY; DISEASE COURSE; DISEASE DURATION; DISEASE PREDISPOSITION; FEMALE; GESTATION PERIOD; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; PREDICTION; PREECLAMPSIA; PREGNANCY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; ANALYSIS OF VARIANCE; BLOOD; CHI SQUARE DISTRIBUTION; PREGNANCY DIABETES MELLITUS; PROSPECTIVE STUDY;

ACTIVINS; ADULT; ANALYSIS OF VARIANCE; CHI-SQUARE DISTRIBUTION; DISEASE SUSCEPTIBILITY; FEMALE; HUMANS; INHIBIN-BETA SUBUNITS; INHIBINS; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY IN DIABETICS; PROSPECTIVE STUDIES;

EID: 33645635585     PISSN: 00016349     EISSN: 16000412     Source Type: Journal    
DOI: 10.1080/00016340500345311     Document Type: Article

References (24)

1. Redman CW, Sacks GP, Sargent IL. Preeclampsia: an excessive maternal inflammatory response to pregnancy. Am J Obstet Gynecol. 1999;180:499-506.
2. Sibai BM, Caritis S, Hauth J, Lindheimer M, VanDorsten JP, MacPherson C, et al. Risks of preeclampsia and adverse neonatal outcomes among women with pregestational diabetes mellitus. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. Am J Obstet Gynecol. 2000;182:364-9.
3. Ekbom P, Damm P, Nogaard K, Clausen P, Feldt-Rasmussen U, Feldt-Rasmussen B, et al. Urinary albumin excretion and 24-hour blood pressure as predictors of pre-eclampsia in Type I diabetes. Diabetologia. 2000;43:927-31.
4. Debieve F, Beerlandt S, Hubinont C, Thomas K. Gonadotropins, prolactin, inhibin A, inhibin B, and activin A in human fetal serum from midpregnancy and term pregnancy. J Clin Endocrinol Metab. 2000;85:270-4.
5. Jenkin G, Ward J, Hooper S, O'Connor A, de Kretser D, Wallace E. Feto-placental hypoxemia regulates the release of fetal activin A and prostaglandin E(2). Endocrinology. 2001;142:963-6.
6. Muttukrishna S, Knight PG, Groome NP, Redman CW, Ledger WL. Activin A and inhibin A as possible endocrine markers for pre-eclampsia. Lancet. 1997;349:1285-8.
7. Laivuori H, Kaaja R, Turpeinen U, Stenman UH, Ylikorkala O. Serum activin A and inhibin A elevated in pre-eclampsia: no relation to insulin sensitivity. Br J Obstet Gynaecol. 1999;106:1298-303.
8. Petraglia F, Aguzzoli L, Gallinelli A, Florio P, Zonca M, Benedetto C, et al. Hypertension in pregnancy: changes in activin A maternal serum concentration. Placenta. 1995;16:447-54.
9. Muttukrishna S, North RA, Morris J, Schellenberg JC, Taylor RS, Asselin J, et al. Serum inhibin A and activin A are elevated prior to the onset of pre-eclampsia. Hum Reprod. 2000;15:1640-5.
10. Keelan JA, Taylor R, Schellenberg JC, Groome NP, Mitchell MD, North RA. Serum activin A, inhibin A, and follistatin concentrations in preeclampsia or small for gestational age pregnancies. Obstet Gynecol. 2002;99:267-74.
11. Zeeman GG, Alexander JM, McIntire DD, Byrd W, Leveno KJ. Inhibin-A and superimposed preeclampsia in women with chronic hypertension. Obstet Gynecol. 2003;101:232-6.
12. Wallace EM, Crossley JA, Ritoe SC, Groome NP, Aitken DA. Maternal serum inhibin-A in pregnancies complicated by insulin dependent diabetes mellitus. Br J Obstet Gynaecol. 1997;104:946-8.
13. Blackburn CA, Keelan JA, Taylor RS, North RA. Maternal serum activin A is not elevated before preeclampsia in women who are at high risk. Am J Obstet Gynecol. 2003;188:807-11.
14. Molsted-Pedersen L, Damm P. How to organize care for pregnant diabetic patients. In: Mogensen CE, Standl E, editors. Concepts for the Ideal Diabetes Clinic. Berlin, New York: de Gruyter; 1992. p. 199-214.
15. Feldt-Rasmussen B, Dinesen B, Deckert M. Enzyme immunoassay: an improved determination of urinary albumin in diabetics with incipient nephropathy. Scand J Clin Lab Invest. 1985;45:539-44.
16. Combs CA, Rosenn B, Kitzmiller JL, Khoury JC, Wheeler BC, Miodovnik M. Early-pregnancy proteinuria in diabetes related to preeclampsia. Obstet Gynecol. 1993;82:802-7.
17. Larsen T, Main K, Andersson AM, Juul A, Greisen G, Skakkebaek NE. Growth hormone, insulin-like growth factor I and its binding proteins 1 and 3 in last trimester intrauterine growth retardation with increased pulsatility index in the umbilical artery. Clin Endocrinol (Oxf). 1996;45:315-9.
18. Knight PG, Muttukrishna S, Groome NP. Development and application of a two-site enzyme immunoassay for the determination of 'total' activin-A concentrations in serum and follicular fluid. J Endocrinol. 1996;148:267-79.
19. Groome NP, Illingworth PJ, O'Brien M, Cooke I, Ganesan TS, Baird DT, et al. Detection of dimeric inhibin throughout the human menstrual cycle by two-site enzyme immunoassay. Clin Endocrinol (Oxf). 1994;40:717-23.
20. Petraglia F, Gomez R, Luisi S, Florio P, Tolosa JE, Stomati M, et al. Increased midtrimester amniotic fluid activin A: a risk factor for subsequent fetal death. Am J Obstet Gynecol. 1999;180:194-7.
21. D'Anna R, Baviera G, Corrado F, Leonardi I, Buemi M, Jasonni VM. Is mid-trimester maternal serum inhibin-A a marker of preeclampsia or intrauterine growth restriction? Acta Obstet Gynecol Scand. 2002;81:540-3.
22. Silver HM, Lambert-Messerlian GM, Star JA, Hogan J, Canick JA. Comparison of maternal serum total activin A and inhibin A in normal, preeclamptic, and nonproteinuric gestationally hypertensive pregnancies. Am J Obstet Gynecol. 1999;180:1131-7.
23. Grobman WA, Wang EY. Serum levels of activin A and inhibin A and the subsequent development of preeclampsia. Obstet Gynecol. 2000;96:390-4.
24. Raty R, Koskinen P, Alanen A, Irjala K, Matinlauri I, Ekblad U. Prediction of pre-eclampsia with maternal mid-trimester total renin, inhibin A, AFP and free beta-hCG levels. Prenat Diagn. 1999;19:122-7.